Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi's European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion
Evotec signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Evotec will also licence-in the majority of Sanofi’s infectious disease research portfolio and initiatives.
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, to develop mRNA vaccines.
A Memorandum on Strategic Partnership in the Area of Non-Communicable Diseases was signed between Sanofi; Health of the Nation League, an All-Russian public organization; and Healthy Cities, Districts and Villages Association.
Sanofi, a leading global pharmaceutical company, is investing €350 million for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.
Shantha Biotechnics, an affiliate of Sanofi Pasteur, has received approval from the World Health Organisation (WHO) for Shanchol, its oral cholera vaccine. The approval is for use at temperatures as h...
Sanofi and Ablynx, a biopharmaceutical company engaged in development of Nanobodies, entered into a definitive agreement under which Sanofi will offer to acquire Ablynx at a price of approximately €3.9 billion